Share on Facebook Share on Twitter Email
Answers.com

Bretylium

 
Drug Info:

Bretylium

Chemical formula:



Last updated: 7/1/2002

Important Disclaimer: The drug information provided here is for educational purposes only. It is intended to supplement, not substitute for, the diagnosis, treatment and advice of a medical professional. This drug information does not cover all possible uses, precautions, side effects and interactions. It should not be construed to indicate that this or any drug is safe for you. Consult your medical professional for guidance before using any prescription or over the counter drugs.

Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
Bretylium
Systematic (IUPAC) name
N-(2-bromobenzyl)-N,N-dimethylethanaminium
Clinical data
MedlinePlus a682861
Pregnancy cat. C(AU) C(US)
Legal status -only (US)
Routes IV, IM
Pharmacokinetic data
Bioavailability NA
Protein binding NA
Metabolism None
Half-life 7-8 hours
Excretion Renal
Identifiers
CAS number 59-41-6 YesY
ATC code C01BD02
PubChem CID 2431
DrugBank APRD00830
ChemSpider 2337 YesY
UNII RZR75EQ2KJ YesY
KEGG D00645 N
ChEBI CHEBI:3172 YesY
ChEMBL CHEMBL1199080 N
Chemical data
Formula C11H17BrN+
Mol. mass 243.163 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Bretylium (also bretylium tosylate) is an antiarrhythmic agent.[1] It blocks the release of noradrenaline from nerve terminals. In effect, it decreases output from the peripheral sympathetic nervous system. It also acts by blocking K+ channels and is considered a class III antiarrhythmic. The dose is 5-10 mg/kg and side effects are hypertension followed by hypotension and ventricular ectopy.

It was patented in 1978 by Marvin Bacaner at the University of Minnesota.[2]

Uses

It is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation. [3]

It is contraindicated in patients with AV (atrioventricular) heart block or digoxin toxicity.

Bretylium should be used only in an ICU setting and should not be used elsewhere due to its dramatic actions and its predominant side effect of hypotension.

References



 
 
Related topics:
Norepinephrine injection
Pseudoephedrine Hydrochloride Oral solution
Acetaminophen, Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride Oral capsule

Post a question - any question - to the WikiAnswers community:

 

Copyrights:

Drug Info. Gold Standard. Copyright © 2008 by Gold Standard. All rights reserved.  Read more
Wikipedia on Answers.com. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article Bretylium Read more

Follow us
Facebook Twitter
YouTube